Wealthcare Advisory Partners’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q2 | – | Sell |
-45
| Closed | -$2K | – | 1423 |
|
2020
Q1 | $2K | Hold |
45
| – | – | ﹤0.01% | 1337 |
|
2019
Q4 | $3K | Hold |
45
| – | – | ﹤0.01% | 1222 |
|
2019
Q3 | $3K | Hold |
45
| – | – | ﹤0.01% | 1178 |
|
2019
Q2 | $3K | Hold |
45
| – | – | ﹤0.01% | 1159 |
|
2019
Q1 | $2K | Hold |
45
| – | – | ﹤0.01% | 1121 |
|
2018
Q4 | $2K | Hold |
45
| – | – | ﹤0.01% | 1105 |
|
2018
Q3 | $3K | Hold |
45
| – | – | ﹤0.01% | 1093 |
|
2018
Q2 | $3K | Hold |
45
| – | – | ﹤0.01% | 1090 |
|
2018
Q1 | $2K | Hold |
45
| – | – | ﹤0.01% | 983 |
|
2017
Q4 | $2K | Hold |
45
| – | – | ﹤0.01% | 945 |
|
2017
Q3 | $3K | Buy |
+45
| New | +$3K | ﹤0.01% | 741 |
|